About
InnoHK Centre for Translational Stem Cell Biology (InnoHK CTSCB) leads global innovation in regenerative medicine, driving next-generation stem cell technology to achieve real-world impact. Through partnerships with the University of Hong Kong and the University of Cambridge and supported by the InnoHK initiative of the Innovation and Technology Commission, we transform pioneering discoveries into innovative applications and commercial successes.
Our patented Expanded Potential Stem Cell (EPSC) technology uniquely enables the generation of every human cell type, including embryonic and extra-embryonic lineages. This breakthrough technology accelerates the development of intelligent drug screening, precision medicine, and cell-based therapies, ultimately improving patient outcomes and enhancing quality of life worldwide.
Driven by our vision for healthy longevity and a spirit of collaboration, InnoHK CTSCB brings together leading experts from around the world, fostering a vibrant culture of innovation. We are dedicated to translating cutting-edge research into life-changing medicine, building a healthier future for all.
Technology
Bio-TechHealth Technology
Additional questions
Other Place of Business
Hong Kong